Skip to Main Content

Paper Details

Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug Efficacy.
SLAS Technol
14
2019
CDKN2A, GBM, GBM spheroid lines, Glioblastoma, Glioblastoma 3D Oncospheres, Hsp90, JHH-136, JHH-520, Mek, NF1, PI3 kinase, PTEN, brain cancer, cell lines, human, in vitro, patient, patient-, spheroid cell lines, spheroid lines, topoisomerase 1
Author NameAffiliation
Rajarshi GuhaDivision of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
Rajarshi GuhaDivision of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
Sam MichaelDivision of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
Zev A BinderPerelmen School of Medicine, University of Pennsylvania
Marc FerrerDivision of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
Gary L GalliaJohns Hopkins University School of Medicine
Craig J ThomasDivision of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
Gregory J RigginsJohns Hopkins University School of Medicine
  • 1 - 8

Datasets

Release 1.2